Methylation–based liquid biopsy facilitates early detection of small cell transformation in ALK -rearranged non–small cell lung cancer
The Oncologist · 08.07.2026 · 31 (8)
DOI: 10.1093/oncolo/oyag271 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Oncologist, online erschienen am 14.07.2026. Verfasst von Jinesh S Gheeya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Carcinoma, Non-Small-Cell Lung, Cell Transformation, Neoplastic, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Histologic transformation from non–small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a rare mechanism of resistance in anaplastic lymphoma kinase (ALK)–rearranged disease. Diagnosis is traditionally dependent on tissue biopsy, which may be limited by lesion accessibility and low disease burden. We report a case of ALK-rearranged lung adenocarcinoma that underwent small cell transformation, in which methylation-based circulating cell-free DNA (cfDNA) analysis detected a small cell lung cancer signature 5 months prior to tissue confirmation. Serial liquid biopsies demonstrated dynamic changes in tumor fraction and histologic composition that correlated with response to chemoradiation and continuation of ALK-directed therapy. This case highlights the potential utility of methylation-based liquid biopsy for early detection and longitudinal monitoring of histologic transformation in oncogene-driven NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA.
- Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA.
- Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA.
- Division of Hematology & Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California 95817, USA.
ORCID-Profile: Jinesh S Gheeya, Christian Rolfo, David P Carbone
Zitieren
APA
Gheeya, J. S., Singh, R., Li, M., Ahmadian, S., Shilo, K., Sen, T., Rolfo, C., Carbone, D. P., Owen, D. H., & Gandara, D. R. (2026). Methylation–based liquid biopsy facilitates early detection of small cell transformation in ALK -rearranged non–small cell lung cancer. The Oncologist, 31(8). https://doi.org/10.1093/oncolo/oyag271
Vancouver
Gheeya JS, Singh R, Li M, Ahmadian S, Shilo K, Sen T, et al. Methylation–based liquid biopsy facilitates early detection of small cell transformation in ALK -rearranged non–small cell lung cancer. The Oncologist. 2026;31(8). doi:10.1093/oncolo/oyag271
BibTeX
@article{Gheeya2026,
author = {Gheeya, Jinesh S and Singh, Raj and Li, Mingjia and Ahmadian, Saman and Shilo, Konstantin and Sen, Triparna and Rolfo, Christian and Carbone, David P and Owen, Dwight H and Gandara, David R},
title = {Methylation–based liquid biopsy facilitates early detection of small cell transformation in ALK -rearranged non–small cell lung cancer},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {8},
doi = {10.1093/oncolo/oyag271}
}
EUVIMED